High throughput protein production and crystallization at NYSGXRC.
Phase II of the Protein Structure Initiative, funded by the NIH NIGMS (National Institute of General Medical Sciences), is a 5-year effort to determine thousands of protein structures. The New York SGX Research Center for Structural Genomics (NYSGXRC) is one of the four large-scale production centers tasked with determining 100-200 structures annually. Almost all protein production is carried out using the high throughput structural biology platform at SGX Pharmaceuticals (SGX), which supplies 120 or more ultrapure proteins per month for NYSGXRC crystallization and structure determination activities. Protocols for PCR, cloning, expression/solubility testing, fermentation, purification, and crystallization are described. General protocols and detailed experimental results for each target are updated weekly at the public PepcDB website (pepcdb.pdb.org/), and all NYSGXRC clones should be available in 2008 through the PlasmID resource operated by the Harvard Institute of Proteomics.
SGX Pharmaceuticals Inc, San Diego, CA, USA.
Michael J
MJ
Sauder
Marc E
ME
Rutter
Kevin
K
Bain
Isabelle
I
Rooney
Tarun
T
Gheyi
Shane
S
Atwell
Devon A
DA
Thompson
Spencer
S
Emtage
Stephen K
SK
Burley
D003001:Cloning, Molecular / Q000379:methods; D018360:Crystallography, X-Ray / Q000379:methods; D009519:New York City; D016133:Polymerase Chain Reaction / Q000379:methods; D011506:Proteins / Q000737:chemistry* / Q000235:genetics / Q000302:isolation & purification*; D040901:Proteomics / Q000379:methods* / Q000458:organization & administration*
D011506:Proteins